Ligayan, Rosalie P.

HRN: 26-20-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/12/2024
11/19/2024
IVT
1.5g
Q8
Cellulitus, Left Leg
Waiting Final Action 
11/12/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/12/2024
11/19/2024
IVT
600mg
Q6
Cellulitus, Left Leg
Waiting Final Action 
11/21/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/21/2024
11/28/2024
IV
4.5g
Q8
Purulent Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: